Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Cash from Operations (2022 - 2023)

Historic Cash from Operations for Therapeutics (LENZ) over the last 2 years, with Q4 2023 value amounting to -$21.0 million.

  • Therapeutics' Cash from Operations rose 650.5% to -$21.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$60.4 million, marking a year-over-year increase of 3137.08%. This contributed to the annual value of -$59.4 million for FY2024, which is 163.8% up from last year.
  • As of Q4 2023, Therapeutics' Cash from Operations stood at -$21.0 million, which was up 650.5% from -$13.1 million recorded in Q3 2023.
  • In the past 5 years, Therapeutics' Cash from Operations ranged from a high of -$12.8 million in Q1 2023 and a low of -$22.4 million during Q4 2022